(Q40246475)

18 September 2017

Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells (English)

1 reference

18 September 2017

1 reference

1 reference

1 reference

Chang CJ

1

1 reference

18 September 2017

Chiu JH

2

1 reference

18 September 2017

Tseng LM

3

1 reference

18 September 2017

Chang CH

4

1 reference

18 September 2017

Chien TM

5

1 reference

18 September 2017

Wu CW

6

1 reference

18 September 2017

Lui WY

7

1 reference

18 September 2017

1 August 2006

1 reference

European Journal of Clinical Investigation

18 September 2017

1 reference

18 September 2017

36

1 reference

18 September 2017

588-596

1 reference

18 September 2017

8

1 reference

18 September 2017

Focus on breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Role of HER2/neu in tumor progression and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Targeted therapy in breast cancer: the HER-2/neu gene and protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survival of breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

A systematic review of herbal medicinal products for the treatment of menopausal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Isoflavones and women's health

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Estrogenic activity of herbs commonly used as remedies for menopausal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Use of dong quai (Angelica sinensis) to treat peri- or postmenopausal symptoms in women with breast cancer: is it appropriate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Synergistic interactions of ferulic acid with ascorbic acid: its cardioprotective role during isoproterenol induced myocardial infarction in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Modulation of iNOS expression by a nitric oxide-releasing derivative of the natural antioxidant ferulic acid in activated RAW 264.7 macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Establishment and characterization of a cell line of human breast carcinoma origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

A novel antiestrogenic mechanism in progesterone receptor-transfected breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Steroid receptors and proliferation in the human breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Influence of marketed herbal menopause preparations on MCF-7 cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Estrogen-Like Activity of Ginsenoside Rg1 Derived from Panax notoginseng

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

The role of MAPK pathways in the action of chemotherapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Aromatase inhibitors for breast cancer: lessons from the laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

Use of alternative medicine by women with early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01676.X

A human cell line from a pleural effusion derived from a breast carcinoma

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/JNCI/51.5.1409

Identifiers

DOI

10.1111/J.1365-2362.2006.01676.X

1 reference

18 September 2017

1 reference